parkinson-s-disease

Documents about parkinson-s-disease

• Mapping the causal chain from genetic risk variants to lipid dysmetabolism in Parkinson's disease.#671156NCBI PubMed Central
• Dopaminergic therapy selectively amplifies hallucination susceptibility in patients with Parkinson’s disease with cortico-striatal hyperconnectivity#676341Europe PMC
• The method matters: free water imaging in Parkinson's disease is not a binary verdict#796505Europe PMC
• A Single Period Investigation to Assess the Tolerability of Healthy Subjects to Oral Sinemet® (Levodopa/Carbidopa)#806686ClinicalTrials.gov
• Effects of Deep Brain Stimulation (DBS) Frequency on Neural Synchrony#811247ClinicalTrials.gov
• Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry#862375ClinicalTrials.gov
• Differential Effects of High and Low Frequency Subthalamic Nucleus Deep Brain Stimulation on Force Steadiness in Patients with Parkinson's Disease: An Exploratory Study#642359Europe PMC
• The BRAINMAP-DBS Study: BRain Network AnalysIs usiNg 7-Tesla MRI and MAgnetoencephalograPhy for Deep Brain Stimulation#866837ClinicalTrials.gov
• Continuous Grip-Force Dataset from Young Adults, Healthy Older Adults, and Patients with Parkinson’s Disease under Visual Feedback Conditions#609532Figshare
• Exercise for Non-Motor Symptoms of Parkinson's Disease: An Evidence-Based Review of Clinical Trials, Dosing Considerations, and Mechanistic Insights.#156749NCBI PubMed Central
• Distribution and impact on quality of life of the pain modalities assessed by the King's Parkinson's disease pain scale#646705Repisalud
• Transcriptional changes in the peripheral blood of at-risk individuals without clinical manifestation of Parkinson’s Disease#4781Europe PMC
• Clinical Algorithm-Guided Approach to Botulinum Toxin Type A Treatment for Axial Postural Abnormalities in Parkinson's Disease.#9027NCBI PubMed Central
• Freezing of Gait in Parkinson's Disease: A Scoping Review on the Path Towards Real-Time Therapies.#13406NCBI PubMed Central
• Serotonergic cortico-limbic and executive network dysfunction in Parkinson’s disease impulse control disorders: a PET-fMRI study#14318HAL (France)
• Parkinson's Disease Detection via Self-Supervised Dual-Channel Cross-Attention on Bilateral Wrist-Worn IMU Signals#120535arXiv CS
• Clinical correlates of a negative cerebrospinal fluid α-synuclein seed amplification assay result in Parkinson's disease#123283Europe PMC
• Predicting Long-Term Depression Progression in Parkinson's Disease: A Machine-Learning Survival Analysis and Risk Score.#156939NCBI PubMed Central
• WDR44 drives de novo α-synuclein aggregation at the lysosomal membrane and promotes neuronal dysfunction in Parkinson's Disease#158259bioRxiv / medRxiv
• Study Assessing Tolerability and Safety and Exploring the Immunogenicity and Therapeutic Activity of AFFITOPE® PD01A in PD-GBA Patients#234477ClinicalTrials.gov
• Care Partners' Information Needs When Caring for a Family Member With Parkinson's Disease: An Explorative Study.#267022NCBI PubMed Central
• Apathy and Reduced Voluntary Activity in Older Adults with Parkinson's Disease: Mechanisms, Clinical Assessment, and Rehabilitation Implications.#367923NCBI PubMed Central
• Explainable 3D vision transformer framework for detecting brain anomalies in neuropsychiatric subtypes of Parkinson's disease.#415535NCBI PubMed Central
• Nocturnal heart rate variability in Parkinson's disease: associations with autonomic dysfunction, cognitive function, and mood symptoms.#457527NCBI PubMed Central
• Lewy pathology largely absent in prefrontal cortices of Parkinson's disease patients undergoing deep brain stimulation#478574Europe PMC
• A curriculum-guided unified framework for robust unsupervised domain adaptation on multi-cohort Parkinson's disease diagnosis.#662790NCBI PubMed Central
• Reply to 'The method matters: free water imaging in Parkinson's disease is not a binary verdict'#796506Europe PMC
• Prevention of Levodopa-induced Dyskinesias by Transcranial Static Magnetic Field Stimulation (tSMS)#873468ClinicalTrials.gov
• Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects#873058ClinicalTrials.gov
• Comparative efficacy of traditional Chinese medicine qigong exercise on motor and non-motor outcomes in Parkinson's disease: a network meta-analysis.#415223NCBI PubMed Central
• Ceramide and Sphingosine-1-Phosphate in Neurodegenerative Disorders and Their Potential Involvement in Therapy#360093IRIS
• Neuromodulação e treinamento de marcha na função motora e equilíbrio na Doença de Parkinson: um ensaio clínico randomizado, controlado e duplo-cego#342745Repositório Institucional da UFPB
• Motor and Cognitive Outcome After Subthalamic Nucleus Deep Brain Stimulation in Patients with Parkinson's Disease Harboring GBA1 Variant.#9024NCBI PubMed Central
• Differential Effects of Lifestyle Indicators on Cognitive Functioning Across Healthy, Dementia, Parkinson's Disease, and Stroke Groups.#12790NCBI PubMed Central
• Structural and Functional Connectomic Signatures of Durable Tremor Control After MRgFUS Thalamotomy in Parkinson’s Disease#151294Unpaywall
• Adaptive regression model for Parkinson's disease diagnosis from speech signals using Box-Cox-based clustering and extremely randomization.#152126NCBI PubMed Central
• Environmental and Medication Effects on Real-World Gait in Parkinson’s Disease: Implications for Context-Aware Movement Biomarkers#157967Europe PMC
• A Three-groups Non-local Model for Combining Heterogeneous Data Sources to Identify Genes Associated with Parkinson's Disease#158628arXiv (OAI)
• Sex differences in the severity of non-motor symptoms in Parkinson's disease: a systematic review and meta-analysis.#165545NCBI PubMed Central
• GPNMB and glycosphingolipid measurements in cerebrospinal fluid and plasma from Parkinson's disease patients in the BioFind cohort#176512bioRxiv / medRxiv
• Targeted memory reactivation during sleep modulates spindle and slow wave density, but not motor memory consolidation, in Parkinson's disease#223951bioRxiv / medRxiv
• Change in deep brain stimulation effect in Parkinson's disease after replacement with a new generation neurostimulator#243514bioRxiv / medRxiv
• Identification of peptides interfering with the PP2Ac And LRRK2 interaction#254242HAL (France)
• Body placement of inertial measurement units differentially affects physical activity assessment accuracy in drug-naïve Parkinson's disease.#266882NCBI PubMed Central
• Cross-Cultural Adaptation and Psychometric Evaluation of the Turkish Version of the Exercise-Specific Parkinson's Disease Questionnaire.#275300NCBI PubMed Central
• Targeting based on patient-specific 7 Tesla MRI connectivity analysis improves deep brain stimulation for Parkinson's disease.#297246NCBI PubMed Central
• Bridging the Rural Mental Health Gap: Telehealth Delivery of Specialized CBT and MBCT for Veterans With Parkinson's Disease.#297404NCBI PubMed Central
• Twenty-five-year experience with apomorphine pump in Parkinson's disease: A real-life long-term retrospective tolerance study#378000HAL (France)
• An application of weighted support vector machines to individualized second-line therapy selection after levodopa in Parkinson's disease.#402663NCBI PubMed Central
• Theta tACS Over the Medial Frontal Cortex Modulates Executive Function in Parkinson's Disease: A Randomized, Sham-Controlled Study.#404219NCBI PubMed Central